Study on the Efficacy of LAS41005 in the Treatment of Actinic Keratosis

NCT00987246 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

470

Enrollment

INDUSTRY

Sponsor class

Conditions

Actinic Keratosis

Interventions

DRUG: Placebo Gel
DRUG: LAS41005
DRUG: LAS106521

Sponsor

Almirall, S.A.